room temperature, 0.049 mL (0.329 mmol) of DBU was added.
After 6 h at room temperature, the mixture was filtered through a
plug of silica gel (EtOAc eluent) before being purified by medium
pressure liquid chromatography (30% EtOAc in hexanes) to afford
0.0231 g (69%) of the desired product as a clear oil: 1H NMR
(500 MHz, CDCl3) δ 7.33-7.25 (m, 7H), 7.22-7.17 (m, 3H), 5.75
(dq, J ) 15.0, 6.5 Hz, 1H), 5.26 (ddq, J ) 15.5, 9.0, 2.0, 2.0, 2.0
Hz, 1H), 4.81 (d, J ) 7.0 Hz, 1H), 4.675 (d, J ) 7.5 Hz, 1H),
4.674 (d, J ) 11.5 Hz, 1H), 4.45 (d, J ) 11.5 Hz, 1H), 4.38 (dddd,
J ) 9.5, 9.5, 7.5, 5.0 Hz, 1H), 4.22 (dd, J ) 9.0, 8.5 Hz, 1H), 4.09
(dd, J ) 9.5, 8.5 Hz, 1H), 3.94 (dd, J ) 8.5, 7.5 Hz, 1H), 3.14 (dd,
J ) 13.5, 4.5 Hz, 1H), 2.72 (dq, J ) 7.0, 7.5 Hz, 1H), 1.73 (dd, J
) 6.5, 2.0 Hz, 3H), and 1.11 (d, J ) 7.5 Hz, 3H); 13C NMR (125
MHz, CDCl3) δ 169.5, 138.2, 132.3, 129.4, 128.7, 128.6, 128.5,
128.1, 127.8, 126.6, 115.1, 91.4, 78.7, 71.7, 69.3, 67.3, 42.0, 39.1,
18.0, and 14.3; HRMS (ESI) calcd for (C24H30NO3+) 380.2220,
found 380.2289; GC-MS tr ) 14.7 min; m/z 379, 355, 341, 327,
288, 258, 243, 242, 228, 218, 207, 188, 161, 150, 117, 91, and 65;
IR (neat) 3030, 2939, 2885, 1667, 1654, 1505, 1455, 1383, 1174,
1100, 1036, 1027, 971, 924, 733, and 698 cm-1; TLC Rf ) 0.50 in
40% EtOAc in hexanes; [R]rt ) +70.5 (c ) 0.210, CHCl3).
for living cationic polymerization, or potential bioactive/
medicinal compounds.1-4
Experimental Section
Conditions B: The Decarboxylative Cyclization of 5d to give
6d. To a 6 mL screw cap vial equipped with a stirbar were added
0.0596 g (0.212 mmol) of (S)-3-benzoyl-4-phenylmethyl-2-oxazo-
lidinone (5d), 0.0590 g (0.440 mmol) of lithium iodide, 0.0233 g
(0.440 mmol) of ammonium chloride, and 1.1 mL of methylene
chloride. The vial was then capped, and the mixture was stirred at
room temperature for 12 h. DBU (0.095 mL, 0.637 mmol) was
added. After 6 h, the mixture was filtered through a plug of silica
gel (EtOAc eluent) before being purified by medium pressure liquid
chromatography (40% EtOAc in hexanes) to afford 0.0381 g (76%)
of the desired product as a clear oil: 1H NMR (500 MHz, CDCl3)
δ 7.59-7.94 (m, 2H), 7.50-7.47 (m, 1H), 7.43-7.40 (m, 2H),
7.33-7.29 (m, 2H), 7.26-7.23 (m, 3H), 4.58 (dddd, J ) 9.0, 9.0,
7.5, 5.0 Hz, 1H), 4.35 (dd, J ) 9.0, 9.0 Hz, 1H), 4.15 (dd, J ) 8.0,
8.0 Hz, 1H), 3.25 (dd, J ) 14.0, 5.5 Hz, 1H), and 2.73 (dd, J )
14.0, 9.0 Hz, 1H); 13C NMR (125 MHz, CDCl3) δ 164.0, 137.9,
131.3, 129.6, 128.5, 128.3, 128.2, 126.5, 71.8, 67.9, and 41.8;
HRMS (ESI) calcd for (C16H15NO + Na+) 260.1046, found
260.1066; GC-MS tr ) 12.0 min; m/z 237, 218, 206, 146, 118,
105, 91, 77, 65, and 51; IR (neat) 3061, 3027, 2960, 2929, 2899,
1651, 1603, 1579, 1495, 1455, 1450, 1358, 1085, 1060, 1025, 967,
780, and 695 cm-1; TLC Rf ) 0.50 in 30% EtOAc in hexanes;
[R]rt ) +8.0 (c ) 0.670, CHCl3).
Acknowledgment. Dedicated to Professor Harold W. Heine
on the occasion of his 85th birthday. This work was supported
by the National Cancer Institute, National Institutes of Health
(CA-76497), and the Lando/NSF Chemistry Summer Research
Program. We thank Heidi A. Dahlmann for assistance with the
scaleup of compound 7.
Conditions A: The Decarboxylative Cyclization of 7 to give
8. To a 6 mL screw cap vial equipped with a stirbar were added
0.0374 g (0.0884 mmol) of (4R)-3-[(2S,3S,4E)-2-methyl-1-oxo-3-
phenylmethoxymethoxy-4-hexenyl]-4-phenylmethyl-2-oxazolidi-
none (7), 0.0575 g (0.429 mmol) of lithium iodide, 0.0105 g (0.198
mmol) of ammonium chloride, and 0.33 mL of chloroform. The
vial was then capped, and the mixture was stirred at 50 °C in an
oil bath for 12 h. After allowing the reaction mixture to cool to
Supporting Information Available: Experimental procedures
1
and full characterization data and copies of the H and 13C NMR
spectra for all compounds prepared. This material is available free
JO800076F
3294 J. Org. Chem., Vol. 73, No. 8, 2008